IL17B and glioblastoma: We identified a six gene cytokine-related signature (CCL2, CCR2, CXCL10, IL10RB, IL17B, and IL17R) capable of dividing glioblastoma patients into a low risk score group with favorable survival and a high risk score group with poor survival.